|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net loss | |||||
| Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of operating lease-right-of use assets | |||||
| Provision for (benefit from) credit losses | |||||
| Stock-based compensation | |||||
| Gain on equity method investment | |||||
| Loss on disposal of property and equipment | |||||
| Provision for excess and obsolete inventory | |||||
| Deferred income taxes | |||||
| Gain on investments, accretion, and amortization, net | |||||
| Interest expenses for accretion of the legal settlement liabilities | |||||
| Change in operating assets and liabilities: | |||||
| Trade accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other assets | |||||
| Trade accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Legal settlement liabilities | |||||
| Deferred revenue | |||||
| Lease liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of marketable securities | |||||
| Maturities of marketable securities | |||||
| Purchase of property and equipment | |||||
| Proceeds from sales of property and equipment | |||||
| Acquisition of business | |||||
| Purchase of intangible assets (patents) | |||||
| Payment for investment | |||||
| Payment for additional investment in Cytek Japan, net of cash acquired | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Repayment of Paycheck Protection Program loan | |||||
| Proceeds from initial public offering, net of underwriting discounts and commissions and other offering costs | |||||
| Proceeds from line of credit | |||||
| Payment for repurchase of shares | |||||
| Proceeds from loan | |||||
| Repayment of loan | |||||
| Proceeds from Employee Stock Purchase Plan | |||||
| Payments for taxes related to net share settlement of equity awards | |||||
| Proceeds from issuance of common stock under employee stock plans | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash: | |||||
| Net decrease in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for taxes, net of refunds | |||||
| Non-cash investing and financing activities: | |||||
| Fixed asset purchases in accounts payable at period end | |||||
| Intangible asset in accrued expenses at period end | |||||
| Accrued excise taxes for share repurchase | |||||
| Derecognition of right-of-use assets | |||||
| Stock option exercise in other receivables at period end | |||||
| Transfer of inventory to property and equipment | |||||
| Operating Lease Right-of-use assets obtained in exchange for operating lease liabilities | |||||
| Holdback amount in business acquisition | |||||
Loading...